"TBI-Based Myeloablative Conditioning Two-Step Haploidentical Allogenei" by Usama Gergis MD, MBA
 

TBI-Based Myeloablative Conditioning Two-Step Haploidentical Allogeneic Hematopoietic Stem Cell Transplant Yields Excellent Outcomes in Fit Patients with High-Risk Hematologic Malignancies, Results of a Prospective Trial

Publication/Presentation Date

11-2024

Volume

144

Issue

1

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article

Share

COinS